What the Peptide Actually Does
These peptides act on appetite, satiety, gastric emptying, and metabolic signaling. They don't produce the reinforcement-driven escalation pattern that defines addiction. People don't crave the peptide more over time, and they don't need higher doses for the same reward effect.
The 2024 Review
A 2024 systematic review on GLP-1 and reward and motivation pathways found something close to the opposite of an addictive pattern: GLP-1 signaling appears to modulate craving and reward toward less compulsive consumption of food, alcohol, and other substances.
Research on GLP-1 peptides in alcohol-use disorder and substance-use disorder is active and growing.
Naming the Fear
"I'm scared to stop taking it" isn't addiction. It's a different feeling, and naming it matters. The fear is usually about appetite returning, the structure of the peptide ending, and the weight coming back. That's a real concern for maintenance, but it isn't a peptide-craving signal in the body.
The discontinuation experience deserves a plan: a maintenance system that doesn't depend on the peptide, ongoing clinician contact during the transition, and an honest expectation that maintenance is its own work.
What this means
References3 sources
How to read these sources
This article uses primary sources and reviews to separate mechanism, human evidence, and context.
- Review
Physiology & Behavior
ElsevierGlucagon-like peptide 1 agonist and effects on reward behaviour: A systematic review Read source
Used Here ForGrounding the addiction discussion in a review of GLP-1 effects on reward and motivation circuitry.
Good ForUnderstanding plausible mechanisms linking GLP-1 signaling to reward and motivation.
Not ForDirect evidence that GLP-1 peptides are or are not addictive; this is mechanistic, not outcome data.
Physiology & Behavior 283:114622 - Review
Medical Sciences
MDPIMechanisms of GLP-1 in Modulating Craving and Addiction: Neurobiological and Translational Insights Read source
Used Here ForSupporting the neurobiological explanation for why GLP-1 may reduce, rather than drive, craving.
Good ForA synthesis of research connecting GLP-1 signaling to craving and addiction-related brain circuits.
Not ForDiagnosing or treating an addiction, or predicting an individual's experience.
Medical Sciences (Basel) 13(3):136 - Review
Physiological Reviews
American Physiological SocietyThe physiology of glucagon-like peptide 1 Read source
Used Here ForGrounding the addiction discussion in core GLP-1 physiology and signaling.
Good ForA comprehensive physiological account of GLP-1 across digestion, insulin, and appetite.
Not ForComparing GLP-1 drugs or making treatment decisions.
Physiological Reviews 87(4):1409-1439